P2RX7 and osteoporosis: Thus, the aim of this review is to review the current state of evidence for the role of the P2X7 receptor in inflammatory-induced bone loss and to discuss the P2X7 receptor as a possible pharmacological target for inhibiting bone loss or even in the treatment of osteoporosis in patients with chronic inflammatory diseases.